KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,601,000 | +14.2% | 202,580 | -13.8% | 2.82% | +728.8% |
| Q2 2022 | $2,277,000 | -2.5% | 235,024 | 0.0% | 0.34% | +17.6% |
| Q1 2022 | $2,336,000 | -15.5% | 235,024 | 0.0% | 0.29% | -13.5% |
| Q4 2021 | $2,766,000 | +3.3% | 235,024 | 0.0% | 0.33% | -6.4% |
| Q3 2021 | $2,677,000 | -18.2% | 235,024 | 0.0% | 0.36% | -19.8% |
| Q2 2021 | $3,274,000 | -53.1% | 235,024 | -37.6% | 0.44% | -56.8% |
| Q1 2021 | $6,975,000 | +46.1% | 376,845 | +39.5% | 1.03% | +35.9% |
| Q4 2020 | $4,773,000 | +15.3% | 270,117 | 0.0% | 0.76% | -4.1% |
| Q3 2020 | $4,138,000 | -40.0% | 270,117 | -0.3% | 0.79% | -46.4% |
| Q2 2020 | $6,900,000 | +64.6% | 270,795 | 0.0% | 1.47% | +21.9% |
| Q1 2020 | $4,192,000 | – | 270,795 | – | 1.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
| Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
| Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
| AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
| Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
| RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
| ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
| Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |